Recombinant Rat B7-H4 protein (rFc Tag)
种属
Rat
纯度
>90 %, SDS-PAGE
标签
rFc Tag
生物活性
未测试
验证数据展示
产品信息
纯度 | >90 %, SDS-PAGE |
内毒素 | <0.1 EU/μg protein, LAL method |
生物活性 |
Not tested |
来源 | HEK293-derived Rat B7-H4 protein Phe29-Gly257 (Accession# Q501W4) with a rabbit IgG Fc tag at the C-terminus. |
基因ID | 295322 |
蛋白编号 | Q501W4 |
预测分子量 | 51.5 kDa |
SDS-PAGE | 65-90 kDa, reducing (R) conditions |
组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
B7-H4, also known as V-set domain containing T cell activation inhibitor 1 (VTCN1/B7x/B7 homolog4/B7S1), belongs to the coinhibitory B7 family ligands. B7-H4 is a type I transmembrane protein and is thought to be an immune checkpoint molecule in the context of tumor immunity. B7-H4 is nominally expressed in normal tissues yet is highly expressed in many types of cancer, including breast cancer, cholangiocarcinoma, endometrial carcinoma, non-small cell and squamous cell lung carcinoma, and ovarian carcinoma. High B7-H4 expression often correlates with shorter cancer patient survival.
参考文献:
1.Song X, et al. (2020) Cancer Discov. 10(12):1872-1893. 2.Kinneer K, et al. (2023) Clin Cancer Res. 29(6):1086-1101. 3.Toader D, et al. (2023) Mol Cancer Ther. 22(9):999-1012. 4.Yu J, et al. (2024) Cell. 187(17):4713-4732.e19.